Adam Jiang heads AllClear ID’s product management team, overseeing all facets of the AllClear Health ID product, from strategy to development to launch. He developed a passion for building healthcare products and serving patients during his time at Harvard University, where he majored in biomedical engineering and minored in computer science.
Prior to AllClear, Adam helped build an investment portfolio of over $100M focused on curative HIV gene therapies scalable to low-income settings at the Bill & Melinda Gates Foundation. During this time, Adam also helped define and implement the Gates Foundation’s COVID-19 diagnostics response strategy – including building relationships with key global stakeholders, such as industry consortia, the NIH, and the WHO. Additionally, as part of McKinsey & Company’s healthcare systems and life sciences practices, Adam has helped create over $1B of impact to organizations, working primarily with health systems across a wide range of functions, including organizational design, procurement, and M&A strategy.